| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Ai Day1 LLC serves as a 10% Owner at DAWN. Across recent SEC filings that breaks down to 9 buys and 0 sells.
Historically, Ai Day1 LLC's trades have earned a middling insider score of 66/100 across 9 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +25.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2023 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 1,475,454 | $10.15 | $14,978,327.50 | +12.9% | +42.5% | +55.1% | |
| Jun 9, 2023 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 769,230 | $13.00 | $9,999,990.00 | +7.2% | +10.8% | -1.6% | |
| Jun 17, 2022 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 1,200,000 | $15.00 | $18,000,000.00 | +12.7% | +44.3% | -16.1% | |
| Jan 20, 2022 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 106,862 | $14.52 | $1,551,908.53 | +1.1% | -24.5% | +52.0% | |
| Jun 1, 2021 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 875,000 | $16.00 | $14,000,000.00 | +10.3% | +28.7% | -69.2% |